Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedFeatured MIMS news
First triple combination MDI licensed for asthma
Trimbow (beclometasone/formoterol/glycopyrronium) can...
Latest MIMS news
Live updates: Coronavirus (COVID-19) in the UK
Use our timeline to follow the latest coronavirus developments...
'Innovative' heart failure treatment recommended by NICE
Dapagliflozin (Forxiga), the first SGLT2 inhibitor...
Pregabalin linked to severe respiratory depression in absence of opioids
The MHRA advises prescribers to consider adjustment...
COVID-19 vaccines substantially reduce infection and hospitalisation risk, 'real-world' data shows
Preliminary data on the impact of COVID-19 vaccination...
Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care
Overuse of short-acting bronchodilator inhalers in...
Phyllocontin to be discontinued
Phyllocontin Continus 225mg and Phyllocontin Forte...
Stay alert to postpartum bleeding risk with antidepressants, MHRA warns
Observational data suggest that the use of SSRIs and...
Join a MIMS Learning webinar on dermatology for skin of colour
In this free live webinar for dermatologists, specialist...
Majority of COVID-19 vaccine side-effects 'mild and short lasting', MHRA analysis confirms
Most adverse reactions reported for the Pfizer/BioNTech...
Licence Changes & Product Updates
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
MIMS bulletins
News and updates straight to your inbox. Prescribing Update: Twice-weekly news bulletin
Alert: Urgent prescribing updates Clinics: Disease-themed monthly round-up